Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05083403 · ClinicalTrials.gov registry record · NA
HPI (Hypotension Prediction Index) Care Trial
A NA study of Cardiopulmonary Bypass Surgery, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT05083403: Active NA study of Cardiopulmonary Bypass Surgery, sponsored by Edwards Lifesciences.
NCT05083403 is a NA study of Cardiopulmonary Bypass Surgery that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05083403, a NA study of Cardiopulmonary Bypass Surgery, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective single-center randomized controlled trial to determine if guided hemodynamic management with the Acumen HPI technology in the OR and ICU can reduce the mean duration of hypotension in cardiac surgery patients requiring cardiopulmonary bypass.
Conditions Studied
Interventions
- DEVICE AcumenTM HPI Software Feature
- OTHER Non-protocolized Standard of Care
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2025-11 |
| Phase | NA |
What the registry record for NCT05083403 still lists
NCT05083403 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Cardiopulmonary Bypass Surgery appearing as the primary indexed condition, and to 2 interventions - of which AcumenTM HPI Software Feature is the first listed.
NCT05083403 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05083403 about?
NCT05083403 is a clinical study titled "HPI (Hypotension Prediction Index) Care Trial". A prospective single-center randomized controlled trial to determine if guided hemodynamic management with the Acumen HPI technology in the OR and ICU can reduce the mean duration of hypotension in cardiac surgery patients requiring cardiopulmonary bypass.
What is the current status of trial NCT05083403?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2022-03-28. Estimated completion is 2025-11.
What conditions does trial NCT05083403 study?
This clinical trial studies the following conditions: Cardiopulmonary Bypass Surgery.
What interventions are being tested in trial NCT05083403?
The interventions under investigation include: AcumenTM HPI Software Feature (DEVICE), Non-protocolized Standard of Care (OTHER).
Who is sponsoring clinical trial NCT05083403?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05083403 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05083403's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI